Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1971-4-3
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0015-0282
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
102-12
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:5101532-Administration, Oral,
pubmed-meshheading:5101532-Adult,
pubmed-meshheading:5101532-Amenorrhea,
pubmed-meshheading:5101532-Androgen Antagonists,
pubmed-meshheading:5101532-Breast Diseases,
pubmed-meshheading:5101532-Child,
pubmed-meshheading:5101532-Female,
pubmed-meshheading:5101532-Humans
|
pubmed:year |
1971
|
pubmed:articleTitle |
Clinical studies with an antigonadotropin-Danazol.
|
pubmed:publicationType |
Journal Article
|